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CASE REPORT
ADULT T-CELL LEUKEMIA/LYMPHOMA ASSOCIATED WITH HTLV-1 INFECTION
IN A BRAZILIAN ADOLESCENT
Antonio Carlos Francesconi do VALLE(1), Maria Clara Gutierrez GALHARDO(1), Ana Claudia Celestino LEITE(1), Abelardo Queiroz Campos ARAÚJO(1),
Tullia CUZZI-MAYA(1), Juan Piñeiro MACEIRA(2) & Jane de Almeida DOBBIN(3)
SUMMARY
We present the case of a 15-year-old patient infected with HTLV-1 who developed a cutaneous T-cell lymphoma, confirmed by
histopathological and immunohistochemical examination, as well as clinically and hematologically confirmed leukemia. The patient
died 3 months after initial presentation of the disease. The rarity of the disease in this age group justifies the present report.
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INTRODUCTION
Human T-cell lymphotropic (HTLV) viruses are retroviruses
classified in 2 groups, HTLV-1 and HTLV-2, which predominantly infect
CD4 and CD8 cells, respectively.
HTLV-1 mainly infects inhabitants of southern Japan16,41, equatorial
Africa8, Malasia50, the Caribbean6, South America (Brazil34, Colombia51,
Peru19, Chile44, Argentina14, and Uruguay28), and the southern United
States5,46. In Brazil, since the introduction of HTLV-1 screening tests in
blood centers, the virus has been found among blood donors with a
prevalence varying from state to state. The highest rate is in Bahia (1.8%)
and the lowest in Santa Catarina (0.08%)2.
HTLV-1 is transmitted by the following routes: sexual21,29; parenteral,
by way of blood product transfusion17; contaminated needles and
syringes35 and vertically, through maternal milk27,29.
HTLV-1 has been associated thus far with adult T-cell leukemia/
lymphoma (ATLL)32 and HTLV-1-associated myelopathy/tropical spastic
paraparesis (HAM/TSP)12. The possible association of HAM/TSP with
ATLL was reported by KAWANO et al.20 and SHARATA et al.40, but
simultaneous presentation of the two diseases in the same individual is
rare. Other diseases may be associated with HTLV-1, including
arthropathies, pneumopathies, uveitis11,30, and dermatologic diseases,
including xerosis, eczematoid seborrhea15, crusty scabies37, balding
folliculitis decalvans1, infective dermatitis24, and prurigo39. However, most
HTLV-1-infected individuals do not develop any disease, thus constituting
asymptomatic carriers.
The first reference to ATLL was by UCHIYAMA et al. in 197743 and
POIESZ et al.32.  HINUMA et al.16 later observed the association between
ATLL and HTLV-1. Subsequent studies have confirmed this association34,49.
ATLL is more common in areas where HTLV-1 is endemic. Patients with
ATLL are usually infected before the age of 20 years, and their relatives
have a high prevalence of HTLV-1 infection. The disease does not usually
appear in more than one member of the family14. Epidemiological studies
focusing on ATLL demonstrate that some 2 to 4% of infected patients
develop neoplasias after a latent period of 20 to 30 years, thus making it
an adult disease. Sexual contact and breastfeeding are the main infection
routes in these patients14. The cutaneous manifestations of ATTL are
common and have different types of lesions7,10.
We present the case of a 15 year-old HTLV-1-infected patient who
developed a cutaneous lymphoma of T-cell origin, confirmed by
histopathological and immunohistochemical examination, and clinically
and hematologically verified leukemia.
CASE REPORT
T.C.S., male, 15 year-old, student, mixed-race, born in Rio de Janeiro,
with HTLV-1 infection diagnosed in July 1997. The patient’s parents
were known to be infected since 1997, and the patient denied prior sexual
contact and drug use. The patient came to the Evandro Chagas Hospital/
FIOCRUZ because of a erythematous infiltrating lesion on his face (Fig.
1) and papulotuberous pruriginous cutaneous lesions on the upper limbs
and torso (Fig. 2) which had appeared one month previously. Two skin
biopsies were performed. Histopathological examination showed dermal
infiltration of medium-to-large-sized lymphocytes with hyperchromatic
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nuclei that varied in size and shape with moderately pleomorphic
lymphoid cells (Fig. 3a). These cells were more intensely and diffusely
distributed in material from the ear (Fig. 3b) and mainly located around
vessels in material from the upper limb. Discrete epidermotropism was
present in addition to nuclear dust and rare mitotic figures (< 1/10 high
power field), particularly in the sample in which the cellular infiltrate
was more exuberant. Neither multinuclear tumor cells nor Pautrier
microabscesses were observed. Using the immunohistochemical
technique, at least half of the cellular infiltrate presented the CD45-RO
antigen (Fig. 4) . In the setting of positive HTLV-1 serology and a clinical
picture involving skin lesions, the histopathological findings were
considered compatible with ATLL. The patient soon developed adynamia
and fever. The cutaneous lesions became infiltrated, and hard loose
cervical lymph nodes appeared, in addition to hepatosplenomegaly. Blood
cell count showed a hematocrit of 45.1% with a white cell count of
57,800, platelet count of 152,000, and lymphoid lineage with a
convoluted or clover-like nuclear contour (polymorphism). Given these
findings, the diagnosis of HTLV-1 associated with ATLL was made.
Rapid disease progression was observed with a worsening of the skin
lesions, bent and salient sternum, splenomegaly, and enlargement of the
superior mediastinum. Further tests revealed LDH of 1035 U/I and
calcium of 10.7 mg/l. The patient was classified as acute-type ATLL and
began treatment with alpha-interferon associated with zidovudine. No
clinical response was observed, and peripheral lymphocyte levels
increased. Systemic chemotherapy was begun. There was an
Fig. 2 - Papulotuberous cutaneous lesions in the upper limbs and torso.
Fig. 1 - Erythematous infiltrating lesions on the face.
Fig. 3 - a) Cytological detail of dermal atypical lymphoid cells. (Hematoxylin-eosin, obj
x100). b) Diffuse dermal infiltrade of lymphoid cells (Hematoxylin-eosin obj X 4).
b
a
Fig. 4 - CD45 RO+ detail lymphoid cells (immunoperoxidase technique, obj x 20).
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approximately 30% reduction in the size and number of the skin lesions,
although the leukemia persisted. The patient developed abdominal pain
and sepsis and died after 73 days, probably due to pulmonary hemorrhage.
DISCUSSION
HTLV-1 is endemic in some areas of Brazil, but prevalence of ATLL
is still unknown. HTLV-1 infection was demonstrated in 11 patients out
of a series of 14 with ATLL, using serological and/or DNA methods34.
Another study in Brazil had also detected HTLV-1 infection in 26% of
188 patients with T-cell lymphoma33. The age bracket for onset of
lymphoma is 40-60 years, although in a review of 28 cases of ATLL in
the state of Bahia, 6 cases were found under 30 years of age3.
Our patient had no history of blood transfusion, drug use, or sexual
contact, and was probably infected by breastfeeding, with a latent period of
15 years. Development of this neoplasia appears to be associated with this
transmission route42. A literature review shows that ATLL is quite rare in
patients under 16 years of age3,9,13,22,26, 34,45,48. The term “adult T cell leukemia/
lymphoma” may be inappropriate insofar as it does not occur only in adults.
In relation to the patient’s family, the mother was an HTLV-1 carrier
and the father, despite being the case index for HTLV-1 infection through
blood donation, refused to be investigated for the disease. The patient’s
sister had negative HTLV-1 serology. It has been reported that individuals
receiving blood transfusions with HTLV-1 develop paraparesis rather than
ATLL. In a recent cohort study that included this patient, no HTLV-1 tax
polymorphism was associated with specific manifestations of the infection36.
Concerning the patient’s ethnic group, higher prevalence has been
observed among black or mixed-race individuals34.
Our patient presented papulotuberous pruriginous cutaneous lesions
in the upper limbs and torso and erythematous infiltrated lesions in the
face, the differential diagnosis of which included lepromatous leprosy,
secondary syphilis, drug-induced eruption, and T-cell cutaneous
lymphoma. The diagnosis of acute subtype ATLL was made later with
the aggravation of the skin lesions and the onset of systemic leukemia
symptoms detected by the blood count, hypercalcemia, increased blood
LDH, and the aggressive course of the disease.
The patient initially responded well to chemotherapy, although
presenting pancreatitis as a complication. He did not respond favorably to
the association of alpha-interferon and AZT, contrary to the results reported
by BAZARBACHI & HERMINE4, in which that regimen was beneficial
in 8 of 10 patients. Three months later he developed a sudden neurological
complication and he died of probable pulmonary hemorrhage.
Histologically, skin involvement in ATTL is characterized by the
presence of atypical lymphocytes in focal clusters or dispersed in the
dermal tissue. Epidermotropism is seen in varying degrees18,25,31,47. In
one of our samples, the neoplastic cells showed a clear perivascular
distribution, but without destruction of vessel walls; it has been shown
that different infiltration patterns can be present when several tissue
samples are obtained from different lesions in the same patient47. Since
the histological alterations can be similar to those found in fungoid
mycosis25, detection of HTLV-1 by tissue polymerase chain reaction can
be used to diagnose these cases23,38.
In endemic areas for HTLV-1 infection, several inflammatory skin
conditions can mimic ATLL, making early diagnosis and immediate
treatment extremely important in light of the infection’s aggressive course.
In this case we identified precisely such an association, and at an early
age.
RESUMO
Leucemia/linfoma de células T do adulto associado a infecção
pelo HTLV-1 em adolescente brasileiro
Apresentamos o caso de um adolescente de 15 anos de idade com
infecção pelo HTLV-1 que desenvolveu linfoma cutâneo de células T,
confirmado por exame histopatológico e imunohistoquímico, assim como
leucemia, diagnosticada por exame clínico e avaliação de sangue
periférico. O paciente morreu 3 meses após o início da doença. A raridade
da doença nesta faixa etária justifica o relato de caso.
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